Cigna Group (CI)
Cigna Group (CI) Stock Price, Analysis & Data
| Bid | 273.43 |
| Market Cap | 72.39B |
| Revenue (ttm) | 282.38B |
| Net Income (ttm) | 6.42B |
| Beta | 0.32 |
| EPS (ttm) | 24.18 |
| PE Ratio (ttm) | 11.33 |
| Forward PE | 8.18 |
| P/B (ttm) | 1.70 |
| P/S (ttm) | 0.26 |
| Earnings Date | Nov 5, 2026 |
| Ask | 273.91 |
| Volume | 244,006 |
| Avg. Volume (20D) | 1,746,082 |
| Open | 272.82 |
| Previous Close | 273.87 |
| Day's Range | 272.51 - 275.47 |
| 52-Week Range | 239.51 - 315.47 |
| Analyst | Buy |
| Price Target | 343 (25.20%) |
| Dividends | $6.24 (2.24%) |
| Ex-Dividend Date | Sep 8, 2026 |
About CI
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug u...
Financial Performance
In 2025, Cigna's revenue was 273.85B, an increase of 11.26% compared to the previous year's 246.15B. Earnings were 5.96B, an increase of 73.47%.
Financial StatementsAnalyst Forecast
According to 24 analyst ratings, the average rating for CI stock is "Buy". The 12-month stock price forecast is 343, which is upside of 25.2% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
